A randomized trial of loading vancomycin in the emergency department

Area of Science:

• Pharmacology
• Infectious Diseases
• Clinical Pharmacy

Background:

• Optimizing vancomycin dosing is crucial for effective bacterial eradication and preventing antimicrobial resistance.
• Current guidelines suggest loading doses, but evidence for faster achievement of therapeutic troughs is lacking.

Purpose of the Study:

• To compare the efficacy of a 30 mg/kg vancomycin loading dose versus a 15 mg/kg traditional dose in achieving therapeutic trough levels at 12, 24, and 36 hours.
• To assess the safety profile, including nephrotoxicity and adverse events, associated with the different vancomycin dosing strategies.

Main Methods:

• A prospective, randomized study involving 99 patients receiving vancomycin in an emergency department setting.
• Patients were randomized to either a 30 mg/kg loading dose or a 15 mg/kg traditional dose, followed by 15 mg/kg every 12 hours for 3 doses.
• Exclusion criteria included patients weighing over 120 kg or with creatinine clearance below 50 mL/min.

Main Results:

• Significantly more patients achieved target vancomycin trough levels (15 mg/L) at 12 hours with the 30 mg/kg loading dose compared to the 15 mg/kg dose (34% vs 3%, P < 0.01).
• This trend persisted at 24 hours, though not statistically significant, and no difference was observed at 36 hours.
• No significant differences in nephrotoxicity or other adverse events were noted between the two dosing groups.

Conclusions:

• A 30 mg/kg vancomycin loading dose is more effective in rapidly achieving therapeutic trough levels within 12 hours compared to a 15 mg/kg dose.
• This enhanced initial dosing strategy does not appear to increase the risk of nephrotoxicity or adverse events.